VINCVincerx Pharma, Inc.

Nasdaq vincerx.com


$ 0.89 $ 0.06 (7.52 %)    

Wednesday, 01-May-2024 15:59:17 EDT
QQQ $ 423.50 $ -1.75 (-0.41 %)
DIA $ 380.50 $ -1.02 (-0.27 %)
SPY $ 501.93 $ -2.47 (-0.49 %)
TLT $ 88.20 $ -0.02 (-0.02 %)
GLD $ 212.71 $ 0.28 (0.13 %)
$ 0.8892
$ 0.82
$ 0.00 x 0
$ 0.00 x 0
$ 0.82 - $ 0.89
$ 0.61 - $ 9.37
300,820
na
18.94M
$ 1.01
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-29-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-07-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-28-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-29-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-17-2021 03-31-2021 10-Q
13 03-22-2021 12-31-2020 10-K
14 11-10-2020 09-30-2020 10-Q
15 09-23-2020 06-30-2020 10-K
16 05-06-2020 03-31-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-vincerx-pharma-vinc-stock-is-falling

Vincerx Pharma shares are trading lower by 9.7% to $0.81 during Friday's session. The company priced an underwritten public...

 vincerx-pharma-sets-pricing-for-new-public-offering-of-shares-and-warrants

Vincerx Pharma, Inc. (NASDAQ:VINC) today announced the pricing of an underwritten public offering of (i) 6,000,000 shares of it...

 vincerx-pharma-announces-proposed-underwritten-public-offering-of-common-stock-and-warrants-no-size-or-amount-disclosed

Vincerx Pharma, Inc. (NASDAQ:VINC) today announced a proposed underwritten public offering of shares of its common stock and ac...

 crude-oil-down-over-1-cognyte-software-shares-plummet

U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.4% on Tuesday. The Dow traded down 0...

 why-tilray-brands-shares-are-trading-lower-by-around-22-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter esti...

 dow-dips-150-points-laser-photonics-shares-spike-higher

U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 150 points on Tuesday. The Dow traded...

 why-is-small-cap-cancer-focused-vincerx-pharma-stock-plummeting-on-tuesday

Preliminary Phase 1 data for VIP236 and updates on pipeline progress presented by Vincerx Pharma at AACR Annual Meeting 2024. R...

 dow-gains-over-50-points-neogen-posts-downbeat-earnings

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 50 points on Tuesday. Following the market openi...

 cantor-fitzgerald-reiterates-overweight-on-vincerx-pharma

Cantor Fitzgerald analyst Li Watsek reiterates Vincerx Pharma (NASDAQ:VINC) with a Overweight.

 why-biophytis-shares-are-trading-higher-by-around-55-here-are-20-stocks-moving-premarket

Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.

 vincerx-pharma-presents-preliminary-phase-1-data-for-vip236-and-updates-on-pipeline-progress-at-aacr-annual-meeting-2024

VIP236 demonstrated positive signs of clinical activity, including tumor reduction, and an improved safety profile in heavily p...

 cantor-fitzgerald-reiterates-overweight-on-vincerx-pharma

Cantor Fitzgerald analyst Li Watsek reiterates Vincerx Pharma (NASDAQ:VINC) with a Overweight.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION